TAMPA, FL--(Marketwire - December 23, 2009) - Stem Cell Therapy International, Inc. (OTCBB: SCII) announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.